Procalcitonin in patients with and without immunosuppression and sepsis

被引:93
作者
AlNawas, B [1 ]
Shah, PM [1 ]
机构
[1] KLINIKUM JW GOETHE UNIV, MED KLIN 3, D-60596 FRANKFURT, GERMANY
关键词
D O I
10.1007/BF01713044
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nigh serum levels of procalcitonin (PCT) are observed in patients with sepsis or severe infection, In a prospective study of 122 hospitalised adult medical patients with sepsis, serum PCT was determined on admission and for 9 days thereafter. Patients with no alteration in their immune system showed high PCT values up to day 5, decreasing to normal levels by day 9. Patients with sepsis and immunodeficiency had high values on days 0 to 2, similar to the first group, but: showed significantly lower levels on the following 3 days, PCT concentrations fell to base Line levels on days 6 to 9 of the sepsis episode in both groups, The observed difference was not significantly related to the kind of causative microorganism or a culture negative sepsis. Leukopenia seemed to go together with lower PCT values after day 2 of the episode, but this could not be proven statistically.
引用
收藏
页码:434 / 436
页数:3
相关论文
共 12 条
[1]  
ADEMA GJ, 1992, J BIOL CHEM, V267, P7943
[2]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[3]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[4]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[5]   PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS [J].
DANDONA, P ;
NIX, D ;
WILSON, MF ;
ALJADA, A ;
LOVE, J ;
ASSICOT, M ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1605-1608
[6]  
GHILLANI PP, 1989, CANCER RES, V49, P6845
[7]  
GRAMM HJ, 1996, CLIN INT CARE S1, V7, P37
[8]  
MOLZ P, 1991, DIAGNOSE LABOR, V41, P41
[9]  
OBERHOFFER M, 1996, CLIN INTENSIVE CARE, V7, P46
[10]  
Raue F, 1992, Henry Ford Hosp Med J, V40, P296